Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Idiopathic pulmonary fibrosis

Click on the title for more information (where available).

Cooper K, Kalita N, Rose M et al. Nintedanib for treating idiopathic pulmonary fibrosis: A Single Technology Appraisal. July 2015

Loveman E, Copley VR, Scott DA, Colquitt JL, Clegg AJ and O’Reilly KM. Comparing new treatments for idiopathic pulmonary fibrosis – a network meta-analysis. BMC Pulmonary Medicine 2015; 15(1):37

Loveman E, Copley VR, Colquitt J, Scott DA, Clegg A, Jones J, et al. The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation. Health Technology Assessment 2015;19(20)

Loveman E, Mendes D, Cooper K, Picot J. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.  A Single Technology Appraisal. Health Technology Assessment. 2012


We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.